Back to Search

Thermo Fisher Scientific Inc

TMO

Life Sciences Tools & Services • Life Sciences Tools & Services

$599.69
+5.69 (+0.96%)

Market Cap: $219.6B

Price Chart

5/10

criteria met

Verdict

Low Growth

Thermo Fisher Scientific Inc (TMO) meets 5 of 10 fundamental criteria on Stoxly's checklist. This company shows limited revenue growth. While other metrics may be acceptable, the low growth rate caps the upside potential.

For educational purposes only — not financial advice. Data may be delayed.

Valuation

Is the stock reasonably priced for what you get?

P/E Ratio

31.5
Target: < 25 Not met

PEG Ratio

3.4
Target: < 2.0 Not met

Price/Book Ratio

4.1
Target: < 3.0 Not met

EV/EBITDA

N/A
Target: < 15Data not available

Growth & Profitability

How fast is the business growing and how efficiently does it earn money?

Revenue Growth

-0.3%
Target: > 10% Not met

ROE

12.6%
Target: > 5% Criteria met

Operating Margin

17.4%
Target: > 10% Criteria met

Return on Assets

6.1%
Target: > 5% Criteria met

Financial Health

Can the company comfortably cover its obligations?

Quick Ratio

1.5
Target: > 1.5 Criteria met

Debt/Equity Ratio

0.7
Target: < 1.0 Criteria met

Free Cash Flow Yield

N/A
Target: > 0%Data not available

Dividend Yield

0.32%
Informational

Dig deeper before you buy

The research platforms we reach for when a stock passes the first screen:

Some links above are affiliate links — Stoxly may earn a commission if you open an account or subscribe, at no extra cost to you. This never influences analysis results. Affiliate disclosure